sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
tttggagctggccttctcaaa | 4092 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyluridine... |
tttggagctggccttctcaaa | 2442 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
tttggagctggccttctcaaa | 2442 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
tttttcaggttgcagtactccca | 4980 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tttttcaggttgcagtactccca | 4980 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tttttcaggttgcagtactccca | 1060 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
tttttcaggttgcagtactccca | 1060 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
tgttggttgtatggcaccatggg | 4903 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tgttggttgtatggcaccatggg | 4903 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tcttcagacactggtaggtggga | 4823 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tcttcagacactggtaggtggga | 4823 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tagtagtcgtaaagttttcttgg | 5069 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tagtagtcgtaaagttttcttgg | 5069 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
aaaagcaaaactgcaagtgaa | 4525 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphate","norInfo":[{"modificationType":"Chemical","modification":["2'-O-methyl","Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphate"]},{"norInfos":[{"sourceData":... |
aaaagcaaaactgcaagtgaa | 4525 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphate","norInfo":[{"modificationType":"Chemical","modification":["2'-O-methyl","Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphate"]},{"norInfos":[{"sourceData":... |
aaaagcaaaactgcaagtgaa | 2875 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
aaaagcaaaactgcaagtgaa | 2875 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
tttgaaacacgaacatagacacc | 5275 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tttgaaacacgaacatagacacc | 5275 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tttgaaacacgaacatagacacc | 3075 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
tttgaaacacgaacatagacacc | 3075 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
tttgaaacacgaacatagacacc | 1197 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
tttgaaacacgaacatagacacc | 1197 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
tttgaaacacgaacatagacacc | 1246 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tttgaaacacgaacatagacacc | 1246 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tttgaaacacgaacatagacacc | 1260 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tttgaaacacgaacatagacacc | 1260 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tccagatgtagagactccttt | 54 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
tccagatgtagagactccttt | 54 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
tccagatgtagagactccttt | 324 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tccagatgtagagactccttt | 324 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tcactctgagagatacactttct | 4630 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tcactctgagagatacactttct | 4630 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tttttgtttggtaacaatatttt | 5576 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tttttgtttggtaacaatatttt | 5576 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tttttgtttggtaacaatatttt | 3376 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
tttttgtttggtaacaatatttt | 3376 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
taggttcttgtttggaaatttgg | 4771 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
taggttcttgtttggaaatttgg | 4771 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
tactgaaacttctttcctgtggt | 1045 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
tactgaaacttctttcctgtggt | 1045 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate 5'-(E)-Vinylphosphonate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"... |
gagggacgatgtccaaaacaa | 3540 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["2'-O-methyl","Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'... |
gagggacgatgtccaaaacaa | 3540 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["2'-O-methyl","Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'... |
gagggacgatgtccaaaacaa | 1890 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
gagggacgatgtccaaaacaa | 1890 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
gagggacgatgtccaaaacaa | 1340 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
gagggacgatgtccaaaacaa | 1340 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
ttggcagacaagctgggattact | 2973 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
ttggcagacaagctgggattact | 2973 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
ttggcagacaagctgggattact | 5173 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
ttggcagacaagctgggattact | 5173 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphate 5'phosphate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-m... |
acccactttctgggcactgca | 3467 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphate","norInfo":[{"modificationType":"Chemical","modification":["2'-O-methyl","Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphate"]},{"norInfos":[{"sourceData":... |
acccactttctgggcactgca | 3467 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyladenosine-3'-phosphate","norInfo":[{"modificationType":"Chemical","modification":["2'-O-methyl","Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methyladenosine-3'-phosphate"]},{"norInfos":[{"sourceData":... |
acccactttctgggcactgca | 1267 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
acccactttctgggcactgca | 1267 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
acccactttctgggcactgca | 1817 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
acccactttctgggcactgca | 1817 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
cagcactggagtgcacagaca | 2108 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
cagcactggagtgcacagaca | 2108 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
cagcactggagtgcacagaca | 1558 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
cagcactggagtgcacagaca | 1558 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
cagcactggagtgcacagaca | 3758 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methylcytidi... |
cagcactggagtgcacagaca | 3758 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylcytidine-3'-phosphate","norInfo":[{"modificationType":"Non natural base","modification":["cm"]},{"modificationType":"Chemical","modification":["Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O-methylcytidi... |
ttccttccaaatttccaaact | 303 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
ttccttccaaatttccaaact | 303 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
ttccttccaaatttccaaact | 33 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
ttccttccaaatttccaaact | 33 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
gaggagaactactgcaggaaa | 3566 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["2'-O-methyl","Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'... |
gaggagaactactgcaggaaa | 3566 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["2'-O-methyl","Phosphate"]}]}],"locations":["1->1"],"infos":["OTHER","2'... |
gaggagaactactgcaggaaa | 1916 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
gaggagaactactgcaggaaa | 1916 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
gaggagaactactgcaggaaa | 1366 | WO2024077148A1 | Plasminogen (PLG) irna compositions and methods of use thereof | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
gaggagaactactgcaggaaa | 1366 | WO2024077148A1 | COMPOSITIONS D'ARNI DE PLASMINOGÈNE (PLG) ET LEURS PROCÉDÉS D'UTILISATION | 20,240,411 | 224 | [
"MX",
"JP",
"IL",
"SG",
"CA",
"EP",
"BR",
"RU",
"CN",
"NZ",
"KR",
"CO",
"TW",
"IN",
"AU",
"ZA",
"CL",
"WO"
] | null |
caacauauuugaucagucu | 64 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gaaugaacugaggcaaauuua | 763 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gaaugaacugaggcaaauuua | 393 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gaaugaacugaggcaaauuua | 1161 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gaaugaacugaggcaaauuua | 1523 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caguugggacauggucuua | 69 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuacuucaacaaaaagugaaa | 342 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuacuucaacaaaaagugaaa | 712 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuacuucaacaaaaagugaaa | 1412 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuacuucaacaaaaagugaaa | 1050 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucuauuucuuuuauuugacuau | 960 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucuauuucuuuuauuugacuau | 590 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucuauuucuuuuauuugacuau | 1608 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucuauuucuuuuauuugacuau | 1246 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aagucuuuaagaccaugucccaa | 977 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aagucuuuaagaccaugucccaa | 1588 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aagucuuuaagaccaugucccaa | 607 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aagucuuuaagaccaugucccaa | 1226 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 509 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 1331 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 1693 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauuugccucaguucauucaaag | 879 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuuacaucgucuaacauag | 97 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cauagugaagcaaucuaau | 34 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uacagauuuuuacacauacucug | 999 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uacagauuuuuacacauacucug | 1333 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uacagauuuuuacacauacucug | 1695 | BR122019026068B1 | Ácido ribonucleico de fita dupla (dsRNA) para inibir a expressão de angptl3 e seu uso, composição farmacêutica e método in vitro para inibir a expressão de ANGPTL3 em uma célula | 20,220,920 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.